Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

Aims: To assess the comparative effects of glucagon-like peptide-1 receptor agonists (GLP-1RA), 4-dipeptidyl peptidase inhibitors (DPP-4I), and metformin treatment during one year on metabolic syndrome (MetS) components and severity in MetS patients. Methods: Prospective study (n = 6165 adults) with...

Full description

Bibliographic Details
Main Authors: Cristina Bouzas, Rosario Pastor, Silvia Garcia, Margalida Monserrat-Mesquida, Miguel Ángel Martínez-González, Jordi Salas-Salvadó, Dolores Corella, Albert Goday, J. Alfredo Martínez, Ángel M. Alonso-Gómez, Olga Fernández-Barceló, Jesús Vioque, Dora Romaguera, José Lopez-Miranda, Ramón Estruch, Francisco J. Tinahones, José Lapetra, Lluís Serra-Majem, Blanca Riquelme-Gallego, Vicente Martín-Sánchez, Xavier Pintó, Miguel Delgado-Rodriguez, Pilar Matía, Josep Vidal, Jersy-Jair Cardenas-Salas, Lidia Daimiel, Emilio Ros, Estefanía Toledo, Josep M. Manzanares, Inmaculada Gonzalez-Monge, Miguel-Ángel Muñoz, Diego Martinez-Urbistondo, Lucas Tojal-Sierra, Carlos Muñoz-Bravo, Salvador Miralles-Gisbert, Marian Martin, Antonio García-Ríos, Sara Castro-Barquero, José Carlos Fernández-García, José Manuel Santos-Lozano, F. Javier Basterra-Gortari, Liliana Gutiérrez-Carrasquilla, Patricia Guillem-Saiz, Alba Satorres, Itziar Abete, Carolina Sorto-Sanchez, Javier Díez-Espino, Nancy Babio, Montse Fitó, Josep A. Tur
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223003499

Similar Items